Skip to content
value.today
PRIM, S.A. logo

PRIM, S.A.

5P1.F
$200 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$284 M
For year ending December-2025
Net income
$19 M
6.6% margin
Official annual report (ESEF)
Employees
—

PRIM, S.A. in brief

PRIM, S.A. is a listed company in the Medical Instruments industry, based in Spain. Its last known market value was $200 M (January 2024); there is no current figure. In the year to December 2025 it had sales of $284 M and a net profit of $19 M, about 7 cents of profit for every dollar of sales. Its shares trade under the symbol 5P1.F (Frankfurt).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

PRIM, S.A. timeline

2 events, 1966–2015
  1. 1966
  2. 🏁
    · approximate
    Incorporated as Prim, S.A.
  3. 2015
  4. •
    Legal Entity Identifier issued
    LEI 959800M75M81U0Y2UX24 registered.

Events of PRIM, S.A. from the GLEIF LEI register. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$75 M$150 M$224 M$299 M20202021202220232024

World rank over time

▼ down 2,523 places since 2020
2020-01-01: #15353#15,35320202021-01-01: #15483#15,48320212022-01-07: #17086#17,08620222022-12-25: #17999#17,99920222023-07-30: #18130#18,13020232024-01-05: #17876#17,8762024

Rank in Spain: #87 (Jan 2020) · #86 (Jan 2021) · #91 (Jan 2022) · #91 (Dec 2022) · #96 (Jul 2023) · #94 (Jan 2024)

Key ratios

market cap and latest results
P/E ratio
—
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
6.6%
Operating margin
8.9%
Return on equity
11.6%
Liabilities / assets
30.0%
Revenue growth
+12.5%

Financial history

USD · fiscal years · source: official annual reports (ESEF)
RevenueNet income
Fiscal year ending Dec 2024: revenue $252M, net income $12M$252MFY24Fiscal year ending Dec 2025: revenue $284M, net income $19M$284MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$284M+12.5%$25M$19M6.6%
Dec 2024$252M—$17M$12M4.7%

Annual results

Revenue
$284 M
Operating income
$25 M
Net income
$19 M

For year ending December-2025 · source: official annual report (ESEF)

Balance sheet

Total assets
$231 M
Total liabilities
$69 M
Total equity
$162 M

As of December-2025

Mutual funds holding PRIM, S.A.#

15 funds hold shares worth $23 M. Since their previous reports 3 added shares and 1 sold, buying $0 M net.
Mutual funds holding PRIM, S.A.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Fidelity Low-Priced Stock FundFidelity Management & Research Company LLC1.28 M$20 M—0.08%−0.1%Jul 31, 2026
🇺🇸 Fidelity Low-Priced Stock K6 FundFidelity Management & Research Company LLC146,063$2 M—0.05%+1.2%Jul 31, 2026
🇺🇸 The Continental Small Company SeriesDimensional Fund Advisors LP40,283$1 M—<0.01%no changeJul 31, 2026
🇺🇸 International Core Equity 2 PortfolioDimensional Fund Advisors LP7,234$0 M—<0.01%+2.9%Jul 31, 2026
🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP5,801$0 M—<0.01%+16%Jul 31, 2026
🇺🇸 Brighthouse/Dimensional International Small Company PortfolioBrighthouse Investment Advisers, LLC3,013$0 M—0.01%no changeJun 30, 2026
🇺🇸 Siit Screened World Equity Ex-Us FundSEI INVESTMENTS MANAGEMENT CORPORATION2,205$0 M—0.02%no changeMay 31, 2026
🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP1,285$0 M—<0.01%no changeJul 31, 2026
🇺🇸 International Sustainability Core 1 PortfolioDimensional Fund Advisors LP1,123$0 M—<0.01%no changeJul 31, 2026
🇺🇸 International Social Core Equity PortfolioDimensional Fund Advisors LP853$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional VA International Small PortfolioDimensional Fund Advisors LP846$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional International Small Cap ETFDimensional Fund Advisors LP28$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional International Sustainability Core 1 ETFDimensional Fund Advisors LP4$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional International Core Equity 2 ETFDimensional Fund Advisors LP8$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional International Core Equity Market ETFDimensional Fund Advisors LP4$0 M—<0.01%no changeJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 15 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Ownership and subsidiaries

Source: GLEIF
PRIM, S.A. directly owns 1 registered entity:

PRIM, S.A. scorecard#

Passes 3 of the 4 checks that could be worked out. Fiscal year 2025.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growth1 of 1
    • ✓Revenue grew in the newest year12.5%Revenue up 12.5% in fiscal 2025.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • –Earnings per share grew in the newest yearEarnings per share of two years are not on file.
    • –Net income higher than five years earlierNet income of five years earlier is not on file.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability2 of 3
    • ✓Profitable in the newest year$19 MNet income $19 M in fiscal 2025.
    • –Profitable in each of the last five yearsFive years of net income are not on file.
    • ✓Operating margin above its peers' median8.9%8.9% against Medical Instruments's median of 7.2% (46 companies).
    • ✗Return on equity above 15%12.7%12.7% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial healthnot known
    • –Short-term assets cover short-term liabilitiesCurrent assets and liabilities are not on file.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returnsnot known
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • –Share count up no more than 2% in a yearShare counts of two years are not on file.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.

Worked out from the statements as filed (esef), the medians of Medical Instruments, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from PRIM, S.A.'s statements, beside the median of Medical Instruments.

PRIM, S.A.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin8.9%7.2%
Net margin6.6%3.8%
Return on equity12.7%3.5%
Revenue growth12.5%8.9%

Margins, returns, growth, debt and cash flow over 5 years.

PRIM, S.A.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in EUR millions; per-share figures in EUR; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

PRIM, S.A.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021
Income statement
Revenue252233217197169
Cost of revenue103104939076
Total costs and expenses232220204191152
Operating income2216169.417
Interest and finance income0.60.50.51.11.2
Interest expense and finance costs0.50.80.80.30.1
Share of profit of associates0−0.1−0.0−0.10
Income before tax2214171123
Income tax5.13.44.42.55.6
Income from continuing operations1711138.417
Net income including minority interests1711138.417
Minority interests' share of net income——000
Net income attributable to shareholders1711138.417
Earnings per share, basic0.980.64———
Earnings per share, diluted0.980.64———
Balance sheet
Cash and cash equivalents189.66.41132
Receivables5050624637
Inventory6770696662
Current assets141135144131136
Property, plant and equipment2119181715
Right-of-use (leased) assets6.96.96.76.75.6
Goodwill11119.59.24.9
Other intangible assets1213149.84.4
Investments in associates00.31.41.40
Non-current assets5655565444
Total assets197190200185180
Accounts payable3738443637
Debt due within a year9.01117108.0
Current liabilities4749624946
Long-term debt7.27.68.51211
Non-current liabilities1212121712
Shareholders' equity138129126120121
Minority interests00.00.00.00.0
Total equity138129126120121
Total liabilities and equity197190200185180
Cash-flow statement
Capital expenditure−1.30−8.8−12−12
Intangible assets bought——−1.6−0.1−0.9
Acquisitions, net of cash acquired0−1.0−2.8−5.2−0.4
Cash from investing activities−10−7.5−3.7−14−8.7
Debt issued9.21402.00
Debt repaid−12−17−0.0−1.00
Shares bought back−0.40———
Dividends paid−8.0−7.6−6.2−8.8−5.4
Cash from financing activities−12−1130−12−15
Exchange-rate effect on cash−0.10.00.1−0.1−0.1
Change in cash8.73.2−4.4−210.6
ReportESEFESEFESEFESEFESEF

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: ESEF annual reports (filings.xbrl.org) · as of Dec 31, 2025. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

How PRIM, S.A. compares in Medical Instruments

  • Revenue$284 M · higher than 38% of 120
  • Net margin6.6% · higher than 41% of 114
  • Revenue growth12.5% · higher than 67% of 49

Peer comparison · Medical Instruments

CompanyMarket capP/ENet marginRev. growth
PRIM, S.A.🇪🇸$200 M—6.6%+12.5%
Intuitive Surgical, Inc.🇺🇸$155.6 B52.6×25.5%+20.5%
EssilorLuxottica S.A.🇫🇷$88.0 B32.1×8.1%+4.5%
HOYA Corporation🇯🇵$56.2 B32.8×25.4%—
Becton, Dickinson and Company🇺🇸$54.0 B57.4×4.2%+8.2%
Alcon Inc.🇨🇭$37.1 B37.9×9.4%+4.9%
ResMed Inc.🇺🇸$35.3 B22.1×27.8%+9.8%
West Pharmaceutical Services, Inc.🇺🇸$27.1 B42.4×18.8%+6.3%
Terumo Corporation🇯🇵$24.9 B27.0×12.0%—

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 15, 2026

Figures from Official annual report (ESEF), value.today research, GLEIF register.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at PRIM, S.A.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show PRIM, S.A.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about PRIM, S.A.? Suggest a correction